Allianz Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-326,305
Closed -$33.1M 2046
2025
Q4
$33.1M Buy
326,305
+232,529
+248% +$18.7M 0.03% 433
2025
Q3
$5.13M Buy
+93,776
New +$4.69M 0.01% 1110
2025
Q2
Sell
-14,397
Closed -$623K 2094
2025
Q1
$623K Sell
14,397
-9,103
-39% -$461K ﹤0.01% 1810
2024
Q4
$1.32M Buy
23,500
+1,997
+9% +$124K ﹤0.01% 1567
2024
Q3
$1.46M Buy
21,503
+9,656
+82% +$545K ﹤0.01% 1515
2024
Q2
$501K Sell
11,847
-3,999
-25% -$220K ﹤0.01% 1836
2024
Q1
$1.09M Sell
15,846
-4,419
-22% -$280K ﹤0.01% 1383
2023
Q4
$1.5M Buy
20,265
+4,986
+33% +$327K ﹤0.01% 1439
2023
Q3
$1.04M Sell
15,279
-1,089
-7% -$92.4K ﹤0.01% 1690
2023
Q2
$1.54M Sell
16,368
-158,086
-91% -$12.3M ﹤0.01% 1402
2023
Q1
$11.8M Buy
174,454
+1,242
+0.7% +$79.8K 0.02% 629
2022
Q4
$8.58M Sell
173,212
-22,758
-12% -$930K 0.02% 727
2022
Q3
$6.37M Buy
195,970
+6,495
+3% +$268K 0.01% 799
2022
Q2
$7.46M Buy
189,475
+43,423
+30% +$2.32M 0.01% 977
2022
Q1
$10.2M Sell
146,052
-1,529
-1% -$112K 0.01% 986
2021
Q4
$11.5M Buy
147,581
+217
+0.1% +$19.2K 0.01% 943
2021
Q3
$14.1M Buy
147,364
+49,800
+51% +$5.26M 0.01% 867
2021
Q2
$12.1M Sell
97,564
-1,641
-2% -$196K 0.01% 785
2021
Q1
$13.1M Buy
99,205
+72,116
+266% +$9.87M 0.01% 748
2020
Q4
$3.59M Buy
27,089
+5,575
+26% +$674K ﹤0.01% 1149
2020
Q3
$2.19M Sell
21,514
-146,673
-87% -$12.7M ﹤0.01% 1234
2020
Q2
$14.6M Sell
168,187
-101,149
-38% -$8.08M 0.02% 749
2020
Q1
$15.6M Sell
269,336
-234,783
-47% -$19.1M 0.02% 656
2019
Q4
$46.6M Buy
504,119
+448,895
+813% +$39.5M 0.04% 457
2019
Q3
$4.99M Sell
55,224
-55,605
-50% -$6.34M ﹤0.01% 1442
2019
Q2
$13.1M Sell
110,829
-73,180
-40% -$7.37M 0.01% 1036
2019
Q1
$15.9M Sell
184,009
-36,188
-16% -$3.08M 0.02% 867
2018
Q4
$13.9M Buy
220,197
+138,597
+170% +$9.51M 0.02% 938
2018
Q3
$6.44M Buy
+81,600
New +$5.32M 0.01% 1449
2018
Q2
Sell
-22,719
Closed -$917K 2641
2018
Q1
$917K Buy
22,719
+15,786
+228% +$770K ﹤0.01% 2237
2017
Q4
$364K Sell
6,933
-135,266
-95% -$7.22M ﹤0.01% 2493
2017
Q3
$6.7M Sell
142,199
-22,356
-14% -$900K 0.01% 1483
2017
Q2
$5.82M Buy
164,555
+101,215
+160% +$3.12M 0.01% 1533
2017
Q1
$1.5M Buy
+63,340
New +$1.26M ﹤0.01% 2100
2014
Q3
Sell
-135,333
Closed -$2.31M 2335
2014
Q2
$2.31M Sell
135,333
-758
-0.6% -$10.4K ﹤0.01% 1154
2014
Q1
$1.93M Sell
136,091
-8,204
-6% -$111K ﹤0.01% 1217
2013
Q4
$1.69M Sell
144,295
-8,349
-5% -$95.8K ﹤0.01% 1256
2013
Q3
$1.8M Buy
+152,644
New +$1.96M ﹤0.01% 1218

Other funds holding EXAS

Allianz Asset Management's EXAS Position: Q1 2026 in Review

Allianz Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 326,305 shares — an estimated $33.1M sold.

Allianz Asset Management first reported a position in EXAS in Q3 2013 and held it in 38 quarters. The position peaked at $46.6M in Q4 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Allianz Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Allianz Asset Management sold 326,305 Exact Sciences shares in Q1 2026, an estimated $33.1M.
  • Allianz Asset Management first reported a position in Exact Sciences in Q3 2013 and held it in 38 quarters.
  • Allianz Asset Management's Exact Sciences position peaked at $46.6M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.